oxyphenonium has been researched along with Prostatic Hyperplasia in 1 studies
Oxyphenonium: A quaternary ammonium anticholinergic agent with peripheral side effects similar to those of ATROPINE. It is used as an adjunct in the treatment of gastric and duodenal ulcer, and to relieve visceral spasms. The drug has also been used in the form of eye drops for mydriatic effect.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BUYTENDIJK, HJ | 1 |
| MAESEN, F | 1 |
1 other study available for oxyphenonium and Prostatic Hyperplasia
| Article | Year |
|---|---|
[VALUE OF ANTRENYL AS A BRONCHODILATOR. COMPARATIVE STUDY WITH RESPECT TO AMINOPHYLLINE].
Topics: Aminophylline; Asthma; Bronchodilator Agents; Geriatrics; Humans; Male; Oxyphenonium; Parasympatholy | 1963 |